Home > Insider Trading > Filing (0001209191-21-023063)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1789769	Instil Bio Inc.	TIL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402856	Jr Kent R Mcgaughy	C/O Instil Bio, Inc. 3963 Maple Avenue, Suite 350 Dallas TX 75219		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-23	7,074,608	$0.00	7,074,608	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-03-23	954,182	$0.00	8,028,790	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2021-03-23	450,000	$20.00	8,478,790	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2021-03-23	5,895,507	$0.00	7,074,608	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-03-23	795,152	$0.00	954,182	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.
The securities are held by Ibisibill, LP (the "LP"). CPMG, Inc. is the general partner of the LP and has voting and investment control over theshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed toshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficialownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein.